ATE178058T1 - Verfahren zur herstellung von gewissen biphenyltetrazolderivaten - Google Patents

Verfahren zur herstellung von gewissen biphenyltetrazolderivaten

Info

Publication number
ATE178058T1
ATE178058T1 AT92309968T AT92309968T ATE178058T1 AT E178058 T1 ATE178058 T1 AT E178058T1 AT 92309968 T AT92309968 T AT 92309968T AT 92309968 T AT92309968 T AT 92309968T AT E178058 T1 ATE178058 T1 AT E178058T1
Authority
AT
Austria
Prior art keywords
biphenyltetrazole
derivatives
producing certain
disclosed
producing
Prior art date
Application number
AT92309968T
Other languages
English (en)
Inventor
William V Murray
Ronald Russell
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of ATE178058T1 publication Critical patent/ATE178058T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92309968T 1991-11-01 1992-10-30 Verfahren zur herstellung von gewissen biphenyltetrazolderivaten ATE178058T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/786,666 US5252753A (en) 1991-11-01 1991-11-01 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof

Publications (1)

Publication Number Publication Date
ATE178058T1 true ATE178058T1 (de) 1999-04-15

Family

ID=25139265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92309968T ATE178058T1 (de) 1991-11-01 1992-10-30 Verfahren zur herstellung von gewissen biphenyltetrazolderivaten

Country Status (11)

Country Link
US (1) US5252753A (de)
EP (1) EP0540356B1 (de)
JP (1) JP3145813B2 (de)
AT (1) ATE178058T1 (de)
AU (1) AU651014B2 (de)
CA (1) CA2081847A1 (de)
DE (1) DE69228727T2 (de)
DK (1) DK0540356T3 (de)
ES (1) ES2130161T3 (de)
GR (1) GR3030330T3 (de)
SG (1) SG47012A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
CA2111662C (en) * 1992-12-17 2004-11-23 Hiroaki Yanagisawa Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
PT788487E (pt) * 1994-10-27 2001-11-30 Novartis Ag Processo para a preparacao de tetrazoles
FR2753705B1 (fr) * 1996-09-20 1999-08-06 Procede pour la preparation de derives de 4-methyl-biphenyle
JPWO2002083127A1 (ja) * 2001-04-09 2004-09-30 宮田 敏男 蛋白修飾物生成抑制組成物
EP1571150A1 (de) * 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Prozess zur Herstellung von Tryptase Hemmstoffen
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
US20060074117A1 (en) * 2004-09-02 2006-04-06 Lilach Hedvati Purification of olmesartan medoxomil
JP4511550B2 (ja) * 2004-09-02 2010-07-28 テバ ファーマシューティカル インダストリーズ リミティド オルメサルタンメドキソミルの調製法
EP1749828A1 (de) 2005-08-04 2007-02-07 Farmaprojects S.L. Verfahren zur Herstellung eines Angiotensin-II-Antagonisten
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (de) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2615918A4 (de) * 2010-09-17 2014-01-29 Glaxosmithkline Ip Dev Ltd Fettsäuresynthasehemmer
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
EP0412594B1 (de) * 1989-07-28 1996-01-03 Merck & Co. Inc. Substituierte Triazolinone, Triazolinthione und Triazolinimine als Angiotensin II-Antagonisten
ATE134624T1 (de) * 1990-02-19 1996-03-15 Ciba Geigy Ag Acylverbindungen
US5039814A (en) * 1990-05-02 1991-08-13 Merck & Co., Inc. Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl)benzenes
CN1034934C (zh) 1990-06-19 1997-05-21 明治制果株式会社 血管紧张素ii拮抗性吡啶衍生物的制备方法
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process

Also Published As

Publication number Publication date
AU2740492A (en) 1993-05-06
GR3030330T3 (en) 1999-09-30
ES2130161T3 (es) 1999-07-01
EP0540356A2 (de) 1993-05-05
DK0540356T3 (da) 1999-10-11
CA2081847A1 (en) 1993-05-02
JPH05279350A (ja) 1993-10-26
DE69228727D1 (de) 1999-04-29
US5252753A (en) 1993-10-12
EP0540356B1 (de) 1999-03-24
EP0540356A3 (en) 1993-08-25
JP3145813B2 (ja) 2001-03-12
AU651014B2 (en) 1994-07-07
SG47012A1 (en) 1998-03-20
DE69228727T2 (de) 1999-08-19

Similar Documents

Publication Publication Date Title
ATE178058T1 (de) Verfahren zur herstellung von gewissen biphenyltetrazolderivaten
DE69210347D1 (de) Verfahren zur Herstellung von Zwischenprodukten zur Verwendung in der Herstellung von Alkoxyiminoacetamide
ATE227292T1 (de) Herstellung von camptothecinderivaten durch intramolekulare cyclisierung
ATE174903T1 (de) Neues verfahren zur herstellung von 7- (substituierten)-9-((substistuierter
ATE207884T1 (de) Verfahren zur herstellung von aminobenzol- derivaten
ATE157647T1 (de) Verfahren zur herstellung von alpha- ketoamidderivaten
ATE127809T1 (de) Verfahren zur herstellung von verbindungen zur behandlung der gutartigen prostatahypertrophie.
ATE531702T1 (de) Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür
ATE96464T1 (de) Verfahren zur herstellung von thiolen.
DE69622862D1 (de) Verfahren zur herstellung von zyklischen verbindungen
ATE272061T1 (de) Friedel-craft verfahren zur herstellung von thioxanthonen
DE69521012D1 (de) Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten
DE60335865D1 (de) Verfahren zur herstellung von cilostazol
DE60116201D1 (de) Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen
ATE157971T1 (de) Verfahren zur herstellung von aminotriazin- derivaten
ATE159246T1 (de) Verfahren zur herstellung von (s)-vinyl- und (s)- allenyl-gaba
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
ATE177737T1 (de) Verfahren zur herstellung von 5-arylhydantoin
ATE127784T1 (de) Verfahren und zwischenprodukte für die herstellung von 2-hydroxy-3-sulfido-3- phenylpropansäuren.
ATE116288T1 (de) Verfahren zur herstellung von sulfonylisocyanaten.
DE69418802D1 (de) Verfahren zur Herstellung von N-Alkylacetamiden
ATE248841T1 (de) Verfahren zur herstellung von penicilling- phenylester
DE69615570D1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
DE69611136D1 (de) Verfahren zur Herstellung von optisch aktivem (S)-(-)- und (R)-(+)- Deoxyspergualin und Zwischenprodukte dafür

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee